Home Diagnostics eyes global expansion with $215m Nipro merger
This article was originally published in Clinica
Executive Summary
US diabetes testing firm Home Diagnostics is to grow into a global business after agreeing to merge with Japanese medtech and pharma manufacturer Nipro.